Myalepta shortage status
1 active shortage notice across 1 country.
Last updated 8 Aug 2026 · sourced from official medicines regulators
- Generic name (INN)
- Myalepta
- Class
- Auto-created by Agencia Española de Medicamentos — Problemas de Suministro scraper
Where Myalepta is in shortage
Why Myalepta is in shortage
- regulatory action — e.g. “La AEMPS ha autorizado unidades por comercialización excepcional. acondicionadas en un idioma distinto al castellano.” (Spain)
Frequently asked questions
Is Myalepta currently in shortage?
Yes. As of the latest regulator updates, Myalepta has 1 active shortage notice across 1 country (Spain). Status is refreshed daily from official regulatory sources.
Why is Myalepta in shortage?
Regulators attribute the current Myalepta shortages to regulatory action. The exact cause varies by country and product — each notice on this page links to the official source.
When will the Myalepta shortage be resolved?
Regulator-estimated resolution dates currently range from 26 May 2027 to 26 May 2027, depending on country and product. These estimates come from the manufacturers via regulators and often change — check the per-country table above for the latest.
Where does this Myalepta shortage data come from?
Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ regulators across 50+ countries and never publishes unsourced shortage claims.
Get alerted when Myalepta status changes
Free for individual pharmacists and clinicians — watchlists, email alerts, alternatives and country-by-country product detail.
Create a free accountData on this page is aggregated from official national medicines regulators and updated daily. It is provided for information only and requires verification before clinical use. Mederti is not affiliated with or endorsed by any regulator.